← Eichor
Study identifier: NCT07194174 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Physical Training in Individuals With Hypokalemic and Hyperkalemic Periodic Paralysis

Condition: Hypokalemic Periodic Paralysis · Hyperkalemic Periodic Paralysis  ·  Sponsor: Rigshospitalet, Denmark

PhaseNA
Planned participants36
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study wishes to investigate the effects of strength exercise in patients with either HypoPP or HyperPP. The investigators wishes to include participants already diagnosed with either HypoPP or HyperPP in af 24 week prospective study where the patients will be tested and asked to fill out questionnaires three times. These appointments will be schedueled at week 0, week 12 and week 24. In the time period between week 12 and week 24, the patients will have a personalized strength exercise program, which they will have to follow these 3 months. The exercise will be supervised by one or more of the investigators. We will also assess the muscle structure and function cross sectionally.

This description comes directly from the study's public registry record.

Talk to the study team

Annica B Enegaard  ·  +4535456135  ·  annica.buss.enegaard.01@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Rigshospitalet, Copenhagen Neuromuscular CenterCopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07194174